Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Friday 11 October, 2019

Bank of NY Mel Corp

Form 8.3 - AbbVie Inc.

RNS Number : 6784P
Bank of New York Mellon Corp. (The)
11 October 2019
 

Ap19

 

 

FORM 8.3

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1.       KEY INFORMATION

 

Name of person dealing (Note 1)

The Bank of New York Mellon Corporation and its subsidiaries, 1.

The Bank of New York Mellon, 2. BNY Mellon Investment Adviser, Inc., 3. Mellon Investments Corporation, 4. BNY Mellon Service Kapitalanlage-Gesellschaft mbH, 5. BNY Mellon Trust of Delaware, 6. BNY Mellon, National Association, 7. Lockwood Advisors, Inc.

Company dealt in

AbbVie Inc.

Class of relevant security to which the dealings being disclosed relate (Note 2)

US$0.01 common stock

Date of dealing

10 October 2019

 

2.         INTERESTS AND SHORT POSITIONS

 

(a)        Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

 

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

15,909,564    1.08%

 

(2) Derivatives (other than options)

 

 

(3) Options and agreements to purchase/sell

 

900           0.0001%

Total

15,909,564    1.08%

900           0.0001%

             

 

 

 

 

 

 

 

 

(b)        Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

             

Ap20

 

1.       DEALINGS (Note 4)

 

(a)      Purchases and sales

 

 

Purchase/sale

 

Number of relevant securities

 

Price per unit (Note 5)

Purchase

Sale

Transfer Out

Purchase

Transfer In

Purchase

Sale

Purchase

Sale

Transfer Out

Transfer In

Purchase

Transfer Out

29

139

81

2,416

739

2,357

8,217

1,000

502

332

365

35

5,073

 

 

USD 73.39
USD 74.23
N/A
USD 74.45
N/A
USD 74.44
USD 74.45
USD 73.80
USD 74.02
N/A
N/A
USD 73.30
N/A





 



 




 

 

 

(b)      Derivatives transactions (other than options transactions)

 

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

 

 

 

 

 

 

(c)      Options transactions in respect of existing relevant securities

 

 

(i)       Writing, selling, purchasing or varying

 

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

 

 

(ii)      Exercising

 

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

 

 

(d)      Other dealings (including transactions in respect of new securities) (Note 4)

 

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

Ap21

2.       OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

 

 

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any 
relevant securities to which any derivative referred to on this form is referenced. If none, this
should be stated.

 

 

     None

 

 

 

 

Is a Supplemental Form 8 attached? (Note 9)                                            Yes

 

Date of disclosure

11 October 2019

Contact name

Ivan Arias

Telephone number

516-338-3370

If a connected EFM, name of offeree/offeror with which connected

 

If a connected EFM, state nature of connection (Note 10)

 

 

 

 

 

Ap23

 

 

 

SUPPLEMENTAL FORM 8

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

 

 

 

DETAILS OF OPEN POSITIONS

 

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

 

OPEN POSITIONS (Note 1)

 

 

 

Product name,

e.g. call option

Written, or purchased

Number of relevant securities to which the option or derivative relates

Exercise price (Note 2)

Type, e.g. American, European etc.

Expiry date

Call Option

Written

900

USD 82.5

American

17 January 2020

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Notes

 

1. Where there are open option positions or open derivativepositions (except for CFDs), full details should 
be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

 

2.          For all prices and other monetary amounts, the currency must be stated.

 

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
ISEUAUSRKVARAAA

a d v e r t i s e m e n t